Dr. Felciano is a visionary founder, operator, and AI strategist with more than two decades of experience driving innovation at the intersection of data, technology, and life sciences. He founded Ingenuity, a pioneer in AI-driven genome interpretation and precision medicine, which played an industry-leading role in advancing data-driven systems biology for biopharma R&D. Ingenuity was acquired by QIAGEN in 2013 as the cornerstone for their AI efforts. At QIAGEN, Dr. Felciano launched and led the strategy for QIAGEN Digital Insights (QDI)—the company’s global AI and data science business unit—guiding it through five acquisitions and scaling it to nearly $100M in revenue over five years, helping transform QIAGEN into a recognized leader in digital solutions for life sciences. Dr. Felciano is currently the founder and CEO of Digital Alchemy, a strategy consultancy that helps organizations unlock AI, digital transformation, and data innovation. As a board member and strategic advisor to Supreme Group, ARPA-H, IMIDomics, Pangaea, Melio, and other biotech, digital health, and life sciences organizations, Dr. Felciano brings a unique combination of technical depth, commercial acumen, and platform-scale leadership. Dr. Felciano holds a Ph.D. in biomedical data science from Stanford Medical School. Here at Compass, Dr. Felciano brings visionary insight and deep entrepreneurial experience to fuel innovation, scale, and real-world clinical impact.